Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study
Ronnie Shapira‐Frommer, Linda Mileshkin, L. V. Manzyuk, Nicolas Penel, Matthew Burge, Sarina A. Piha‐Paul, Eugenia Girda, José A. López-Martín, Marloes G. J. van Dongen, Antoîne Italiano, Lei Xu, Fan Jin, Kevin Norwood, Patrick A. Ott
Topics & Concepts
MedicinePembrolizumabInternal medicineDiscontinuationResponse Evaluation Criteria in Solid TumorsClinical endpointGastroenterologyVulvar cancerPhases of clinical researchOncologySurgeryCancerChemotherapyImmunotherapyClinical trialEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses